Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > 90 Days Fireside Chat

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Sep 25, 2023 1:04pm

227 Views

Post# 35652560

RE:RE:90 Days Fireside Chat

As I have posted a few times.
Anything new & exciting would be prefaced with a news release.
nothing can be announced at any type of conference, without a public announcement first.
So.....unless there is a N.R. Before the fireside chat, the answer is nothing new.
They must inform any important updates through appropriate channels, aka SEDAR & newswire.
else those watching the fireside chats would have special information.
regards

<< Previous

Bullboard Posts

Next >>

Grand Portage Resources pioneers new gold exploration in Alaska